Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07894133

Gait Parameters in Breast Cancer Receiving Chemotherapy Patients

Sponsor: Adly A Adam

View on ClinicalTrials.gov

Summary

Breast cancer is considered the most common type of malignancies, it is the most frequently diagnosed representing around 2.3 million cases. Where, their chemotherapy may cause fatigue affecting the overall quality of patient's life. Gait and balance are fundamental for activities of daily living and maintaining functional independence.

Official title: Assessment of Gait Parameters in Breast Cancer Patients Receiving Chemotherapy

Key Details

Gender

FEMALE

Age Range

40 Years - 50 Years

Study Type

OBSERVATIONAL

Enrollment

360

Start Date

2026-10-01

Completion Date

2027-03-01

Last Updated

2026-10-26

Healthy Volunteers

No

Interventions

OTHER

Gait parameter assessment

A Biodex Gait Trainer 3 (BIODEX MEDICAL SYSTEMS, INC., New York, NY, model NO. 601-1-M90, EN 60601- 1 USA), is a device which is used to assess the spatiotemporal gait parameters of patients . It consists of a treadmill with an instrumented deck that monitors and records kinematic gait parameters including gait speed, step cycle, step length, and time on each foot (step symmetry). The patient will instructed to stand on the treadmill holding on handrails to ensure safety. Each patient will be asked to walk continuously for 3 minutes, till the evaluation session ended, and the gait trainer slow down gradually until it stopped. Three successive trials will be done for each patient. The mean value of each variable of spatiotemporal parameters of gait \[walking speed (meters per seconds), step cycle (cycle per second), step length (meter), and time on each foot (seconds)\] will be recorded.

Locations (1)

National Cancer Institute

Cairo, Cairo Governorate, Egypt